Evidence map›Paper›PMID 41254822›Full record

ArticleBMC psychology2025

Validation of the Chinese version of the 12-Item multiple sclerosis walking scale in individuals with multiple sclerosis: a psychometric and item response theory analysis.

He Zhang, Nabi Nazari

Abstract readValidation Study
In one paragraph

Article in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

He ZhangCenter for Mental Health Education and Counseling, Zhejiang Wanli University, Ningbo, 315000, China. Zhanghe@zwu.Edu.Cn.
Nabi NazariDepartment of Psychology, School of Literature and Human Sciences, Lorestan University, Khorramabad, Iran. Nazariirani@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 12-item Multiple Sclerosis Walking Scale (MSWS-12) is widely used to assess patient-perceived walking disability in individuals with multiple sclerosis (MS). Despite its international application, a validated Mandarin version has been lacking. This study aimed to translate and validate the Chinese version of the MSWS-12 and examine its psychometric properties using both classical test theory (CTT) and item response theory (IRT) approaches.

methodsThe MSWS-12 was translated into Chinese following international guidelines, including forward and backward translation, expert panel review, and cognitive debriefing. Cognitive debriefing was conducted with 20 individuals with MS (10 urban, 10 rural; 40% with a high school education or lower), confirming that all items were clear, culturally relevant, and conceptually equivalent. Participants were recruited from neurology clinics and included adults with clinically confirmed MS who had sufficient cognitive and physical function to complete the self-report instrument. Measurement properties were evaluated in accordance with the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guideline, including internal consistency, test-retest reliability, structural validity, measurement invariance, and item-level analysis using the Graded Response Model (GRM).

resultsParticipants (N = 292) had a mean age of 41.72 years (SD = 5.23), with 60.6% identifying as female, and represented a diverse educational backgrounds. The Chinese version of the MSWS-12 demonstrated excellent internal consistency (Cronbach's α = 0.92; McDonald's ω = 0.91) and strong test-retest reliability (intraclass correlation coefficient [ICC] = 0.91, 95% CI [0.86, 0.94]), indicating high temporal stability. CFA supported a unidimensional structure with excellent model fit (CFI = 0.987, TLI = 0.984, IFI = 0.987, SRMR = 0.032, RMSEA = 0.038. 90% CI [0.015, 0.056]). Measurement invariance was confirmed across sex, residency, and disease duration at configural, metric, scalar, and strict levels (ΔCFI < 0.010, ΔRMSEA < 0.015). IRT analysis showed high item discrimination parameters (α = 2.01 - 2.95) and well-ordered respnse thresholds. No evidence of differential item functioning (DIF) was found (Δpseudo-R² < 0.02). Criterion-related validity was supported by strong correlations with the T25FW (r = .64, 95% CI [0.57, 0.70]) and the 6MWT (r = -.61, 95% CI [-0.67, -0.53]). Convergent validity was indicated by moderate associations with the EDSS (r = .47, 95% CI [0.37, 0.55]) and the MFIS (r = .45, 95% CI [0.36, 0.54]), while discriminant validity was confirmed by a weak association with the PHQ-9 (r = .28, 95% CI [0.17, 0.38]).

conclusionThe Chinese version of the MSWS-12 is a psychometrically sound, culturally valid tool for assessing ambulatory disability in Mandarin-speaking individuals with MS. Its demonstrated reliability, validity, and measurement invariance support its application in clinical practice and cross-cultural research.

Indexed as

Disability EvaluationMultiple SclerosisWalkingAdultChinaFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsTranslationsItem response theoryMeasurement invarianceMSWS-12, psychometric validationMultiple sclerosisPatient-reported outcomesWalking disability

Identifiers

PMID41254822
PMCPMC12625310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.